Authors:
Schafer, H
Berger, C
Aepinus, C
Hebart, H
Beck, R
Kaiserling, E
Kanz, L
Einsele, H
Knecht, H
Citation: H. Schafer et al., Molecular pathogenesis of Epstein-Barr virus associated posttransplant lymphomas: New insights through latent membrane protein 1 fingerprinting, TRANSPLANT, 72(3), 2001, pp. 492-496
Authors:
Knecht, H
Berger, C
McQuain, C
Rothenberger, S
Bachmann, E
Martin, J
Esslinger, C
Drexler, HG
Cai, YC
Quesenberry, PJ
Odermatt, BF
Citation: H. Knecht et al., Latent membrane protein 1 associated signaling pathways are important in tumor cells of Epstein-Barr virus negative Hodgkin's disease, ONCOGENE, 18(50), 1999, pp. 7161-7167
Authors:
Sabo, G
Brodbeck, U
Cardile, N
Viollier, AF
Scheurmann, T
Knecht, H
Citation: G. Sabo et al., Diagnosis of thalassaemias and haemoglobinopathies by HPLC (high performance liquid chromatography): study of 627 patients, SCHW MED WO, 129(34), 1999, pp. 1196-1200
Authors:
Berger, C
van Baarle, D
Kersten, MJ
Klein, MR
Al-Homsi, AS
Dunn, B
McQuain, C
van Oers, R
Knecht, H
Citation: C. Berger et al., Carboxy terminal variants of Epstein-Barr virus-encoded latent membrane protein 1 during long-term human immunodeficiency virus infection: Reliable markers for individual strain identification, J INFEC DIS, 179(1), 1999, pp. 240-244
Authors:
Berger, C
Rothenberger, S
Bachmann, E
McQuain, C
Nadal, D
Knecht, H
Citation: C. Berger et al., Sequence polymorphisms between latent membrane proteins LMP1 and LMP2A do not correlate in EBV-associated reactive and malignant lympho-proliferations, INT J CANC, 81(3), 1999, pp. 371-375